Inventor · disambiguated record
Wolf-Georg Forssmann
Also filed as: FORSSMANN WOLF G · FORSSMANN WOLF-GEORG
39 granted patents·30 pending applications·481 citations·filing 1984–2021
98Inventor score
Files withPHARIS BIOTEC GMBH16FORSSMANN WOLF GEORG12IPF PHARMACEUTICALS GMBH6HAEMOPEP PHARMA GMBH5CARDIORENTIS AG4
Top patents by PatentIndex Score
69 records- 0192US4751284ACardiodilatin, a new peptide hormone and process for its preparationORGANOGEN MED MOLEKULAR FORSCH·Filed 1984·Granted Jun 14, 1988·44 cites·30 claims
- 0289US7732406B2Use of natriuretic peptide for treating heart failureCARDIOPEP PHARMA GMBH·Filed 2006·Granted Jun 8, 2010·24 cites·26 claims
- 0383US5767239AProcess for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of sameBOEHRINGER MANNHEIM GMBH·Filed 1995·Granted Jun 16, 1998·45 cites·8 claims
- 0482US7033997B2Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infectionsPHARIS BIOTEC GMBH·Filed 2004·Granted Apr 25, 2006·33 cites·9 claims
- 0582US4895932AMethod for determining cardiodilatin and fragments thereof and antibodies useful in determination of cardiodilatin and its fragmentsORGANOGEN MEDIZINISCH MOLEKULA·Filed 1988·Granted Jan 23, 1990·27 cites·12 claims
- 0682US4782044AComposition containing cordiodilatin or fragments thereof and methods of obtaining cardiodilatinORGANON MEDIZINISCH MOLEKULARB·Filed 1988·Granted Nov 1, 1988·28 cites·15 claims
- 0781US6831064B1Use of urodilatin for treating chronic kidney failure with residual kidney functionsPHARIS BIOTEC GMBH·Filed 2000·Granted Dec 14, 2004·14 cites·2 claims
- 0878US9045563B2CXC chemokine receptor 4 (CXCR4) antagonistic polypeptideFORSSMANN WOLF-GEORG·Filed 2008·Granted Jun 2, 2015·4 cites·9 claims
- 0977US5744444AHPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereofHAEMOPEP PHARMA GMBH·Filed 1995·Granted Apr 28, 1998·35 cites·6 claims
- 1074US9023794B2Use of natriuretic peptide for treating heart failureCARDIORENTIS AG·Filed 2014·Granted May 5, 2015·2 cites·18 claims
- 1173US8710006B2Use of natriuretic peptide for treating heart failureMITROVIC VESELIN·Filed 2010·Granted Apr 29, 2014·3 cites·28 claims
- 1273US7037896B1Peptide (VIRIP) which inhibits a circulating virus in humans and the use thereofIPF PHARMACEUTICALS GMBH·Filed 2000·Granted May 2, 2006·8 cites·4 claims
- 1371US5449751ACardiodilatin fragment, process for preparing same and use thereofBISSENDORF PEPTIDE GMBH·Filed 1994·Granted Sep 12, 1995·37 cites·4 claims
- 1469US9358271B2Use of natriuretic peptide for treating heart failureCARDIORENTIS AG·Filed 2015·Granted Jun 7, 2016·1 cites·19 claims
- 1568US8106061B2Use of phosphodiesterase inhibitors in the treatment of prostatic diseasesFORSSMANN WOLF-GEORG·Filed 2003·Granted Jan 31, 2012·4 cites·5 claims
- 1668US2015051382A1Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndrome while avoiding a reboundCARDIOPEP PHARMA GMBH·Filed 2014·Application pending·0 cites
- 1767US2009240031A1Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragmentsPHARIS BIOTEC GMBH·Filed 2007·Application pending·0 cites
- 1865US9434780B2Process for preparing human relaxin-2FORSSMANN WOLF-GEORG·Filed 2012·Granted Sep 6, 2016·2 cites·5 claims
- 1964US6326163B1Method for the direct diagnostic detection of genetically caused pathogenic point mutationsPHARIS BIOTEC GMBH·Filed 1997·Granted Dec 4, 2001·31 cites·8 claims
- 2062US5891904AUse of inhibitors of phosphodiesterase IVFORSSMANN WOLF GEORG·Filed 1997·Granted Apr 6, 1999·26 cites·15 claims
- 2162US2013197188A1Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes while avoiding a reboundFORSSMANN WOLF-GEORG·Filed 2011·Application pending·0 cites
- 2261US5571789AUse of urodilatin in pulmonary and bronchial diseasesHAEMOPEP PHARMA GMBH·Filed 1993·Granted Nov 5, 1996·20 cites·11 claims
- 2361US2005106678A1Human circulating cytokine CC-1WOLF GEORG FORSSMANN·Filed 2004·Application pending·0 cites
- 2460US2016303199A1Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes while avoiding a reboundCARDIOPEP PHARMA GMBH·Filed 2015·Application pending·0 cites
- 2559US8293711B2Use of natriuretic peptides for treating angioedema syndromesFORSSMANN WOLF-GEORG·Filed 2008·Granted Oct 23, 2012·0 cites·11 claims
- 2658US2008242609A1Composition for the therapy of diabetes mellitus and adiposityPHARIS BIOTEC GMBH·Filed 2007·Application pending·0 cites
- 2757US2014024585A1Composition for the therapy of diabetes mellitus and adiposityFORSSMANN WOLF GEORG·Filed 2011·Application pending·0 cites
- 2855US10125169B2Protransduzin B, a gene transfer enhancerPHARIS BIOTEC GMBH·Filed 2014·Granted Nov 13, 2018·0 cites·8 claims
- 2955US8791124B2Use of phosphordiesterase inhibitors in the treatment of prostatic diseasesFORSSMANN WOLF-GEORG·Filed 2011·Granted Jul 29, 2014·0 cites·3 claims
- 3055US2023144625A1Polypeptide for the therapy of glomerular kidney disease and analysis of the course and prognosis of dependent syn-dromesPHARIS BIOTEC GMBH·Filed 2021·Application pending·0 cites
- 3155US2018008675A1Use of urodilating for preparing a medicament for treatment of cardiovascular, renal, pulmonary, and neuronal syndromes while avoiding a reboundCARDIORENTIS AG·Filed 2017·Application pending·0 cites
- 3255US2011263509A1Preparation and use of high-purity hemoparatide (hpth-1-37) for the treatment of inflammatory scaling diseases of the skinHAEMOPEP PHARMA GMBH·Filed 2009·Application pending·0 cites
- 3355US2008234187A1Human circulating cytokine CC-1WOLF GEORG FORSSMANN·Filed 2006·Application pending·0 cites
- 3454US2005130891A1Composition for the therapy of diabetes mellitus and adiposityFORSSMANN WOLF GEORG·Filed 2004·Application pending·0 cites
- 3554US2007244037A1Human Chemokine HCC-1 Polypeptides To Improve Stem Cell TransplantationTAP PHARMACEUTICAL PROD INC·Filed 2004·Application pending·0 cites
- 3653US5461142APhosphorylated derivatives of cardiodilatin/ANF peptidesBISSENDORF PEPTIDE GMBH·Filed 1993·Granted Oct 24, 1995·14 cites·5 claims
- 3753US2023149522A1Polypeptide for the prophylaxis and treatment of viral infectionsPHARIS BIOTEC GMBH·Filed 2021·Application pending·0 cites
- 3852US10294272B2Peptides with antagonistic activities against natural CXCR4PHARIS BIOTEC GMBH·Filed 2014·Granted May 21, 2019·0 cites·11 claims
- 3952US6180773B1Tandem cDNAs encoding chemokines CC-1, CC-2, and CC-3FORSSMANN WOLF GEORG·Filed 1997·Granted Jan 30, 2001·9 cites·15 claims
- 4052US2016324931A1Use of Natriuretic Peptide for Treating Heart FailureCARDIORENTIS AG·Filed 2016·Application pending·0 cites
- 4152US2009124541A1Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseasesIPF PHARMACEUTICALS GMBH·Filed 2007·Application pending·0 cites
- 4252US2006122371A1Process for preparing cardiodilatin fragments; highly purified cardiodilatin fragments and intermediate products for the preparation of samePHARIS BIOTEC GMBH·Filed 2005·Application pending·0 cites
- 4351US2010317600A1Process for Preparing Cardiodilatin Fragments; Highly Purified Cardiodilatin Fragments and Intermediate Products for the Preparation of SameIMMER HANSUELI·Filed 2010·Application pending·0 cites
- 4450US6875616B1Process for determining the status of an organism by peptide measurementBIOVISION AG·Filed 1997·Granted Apr 5, 2005·14 cites·23 claims
- 4550US5665861ACardiodilatin fragment, process for preparing same and use thereofHAEMOPEP PHARMA GMBH·Filed 1995·Granted Sep 9, 1997·15 cites·10 claims
- 4648US7741287B2Peptides for the treatment of herpes virus infectionsIPF PHARMACEUTICALS GMBH·Filed 2005·Granted Jun 22, 2010·0 cites·6 claims
- 4746US2021154327A1Protransduzin-d - improved enhancer of gene transferPHARIS BIOTEC GMBH·Filed 2018·Application pending·0 cites
- 4846US2019100557A1Protransduzin b, a gene transfer enhancerPHARIS BIOTEC GMBH·Filed 2018·Application pending·0 cites
- 4944US6849593B1Bifidogenic peptidesPHARIS BIOTEC GMBH·Filed 1998·Granted Feb 1, 2005·8 cites·10 claims
- 5044US2004116652A1Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseasesFiled 2001·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →